Quantification of RNA in HIV type 1 subtypes D and G by NucliSens and Amplicor assays in Abidjan, Ivory Coast

被引:6
作者
Nkengasong, JN
Bile, C
Kalou, M
Maurice, C
Boateng, E
Sassan-Morokro, M
Rayfield, M
Coulibaly, D
Greenberg, AE
Wiktor, SZ
机构
[1] CHU Trenchville, Virol Lab, Abidjan 01, Cote Ivoire
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div AIDS STD & TB Lab Res, HIV Retrovirus Dis Branch, Atlanta, GA 30333 USA
[3] Natl AIDS STD TB Control Program, Abidjan 04, Cote Ivoire
[4] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS & TB Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1089/088922299311015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have compared the performance of the NucliSens and the standard and modified HIV Monitor assays to quantify HIV-1 RNA plasma viral load in 12 tuberculosis patients infected with HIV-1 env subtype D (n = 3) and env subtype G (n = 9) in Ivory Coast. RNA was quantified in ail nine subtype G specimens by the modified Amplicor HIV Monitor (mean, 4.6 log(10) copies/ml; range, 3.1-6.3 log(10)/ml), in seven specimens by NucliSens (mean, 4.4 log(10) copies/ml; range, 2.7-5.5 log(10) copies/ml), and in 6 specimens by the standard Amplicor HIV Monitor assay (mean, 4.2 log(10) copies/ml; range, 3.5-5.0 log(10) copies/ml). All three subtype D samples were amplified by both the modified Amplicor HIV Monitor (mean, 4.5 log(10) copies/ml; range, 3.8-5.1 log(10) copies/ml) and NucliSens (mean, 3.8 log(10) copies/ml; range, 2.8-5.0 log(10) copies/ml); two samples were quantified by the standard Amplicor HIV Monitor assay (mean, 3.0 log(10) copies/ml; range, 2.4-3.6 log(10) copies/mi). Our preliminary results suggest that the modified Amplicor HIV Monitor can accurately quantify HIV-1 RNA viral load in persons infected with subtype D and G strains.
引用
收藏
页码:495 / 498
页数:4
相关论文
共 17 条
[1]   SUBGROUP-G HIV TYPE-1 ISOLATES FROM NIGERIA [J].
ABIMIKU, AG ;
STERN, TL ;
ZWANDOR, A ;
MARKHAM, PD ;
CALEF, C ;
KYARI, S ;
SAXINGER, WC ;
GALLO, RC ;
ROBERTGUROFF, M ;
REITZ, MS .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1581-1583
[2]   Subtype-specific problems with quantification of plasma HIV-1 RNA [J].
Alaeus, A ;
Lidman, K ;
Sonnerborg, A ;
Albert, J .
AIDS, 1997, 11 (07) :859-865
[3]   HIV TYPE-1 SEQUENCE SUBTYPE-G TRANSMISSION FROM MOTHER-TO-INFANT - FAILURE OF VARIANT SEQUENCE SPECIES TO AMPLIFY IN THE ROCHE AMPLICOR TEST [J].
ARNOLD, C ;
BARLOW, KL ;
KAYE, S ;
LOVEDAY, C ;
BALFE, P ;
CLEWLEY, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (08) :999-1001
[4]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[5]   Diverse HIV-1 genetic subtypes in UK [J].
Clewley, JP ;
Arnold, C ;
Barlow, KL ;
Grant, PR ;
Parry, JV .
LANCET, 1996, 347 (9013) :1487-1487
[6]  
Coste J, 1996, J MED VIROL, V50, P293, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt
[7]  
293::AID-JMV3&gt
[8]  
3.0.CO
[9]  
2-3
[10]   Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain [J].
Debyser, Z ;
Van Wijngaerden, E ;
Van Laethem, K ;
Beuselinck, K ;
Reynders, M ;
De Clercq, E ;
Desmyter, J ;
Vandamme, AM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (05) :453-459